Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04955236Phase 1Completed
Phase 1, randomised, double-blind trial of bupivacaine hydrochloride 0.75% injection in pain (2 arms), sponsored by Kasr Al Ainy Hospital. Primary endpoint: Systolic blood pressure at time of skin incision. Started Jul 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04955236.